Literature DB >> 34315848

Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C.

Zhongcheng Zhou1, Peng Du1, Meixing Yu1, Daniel T Baptista-Hon2, Man Miao2, Andy P Xiang3, Johnson Yiu-Nam Lau4, Gen Li5, Kang Zhang6,7,8.   

Abstract

Entities:  

Year:  2021        PMID： 34315848     DOI： 10.1038/s41392-021-00695-0

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  5 in total

1.  Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant.

Authors:  Gen Li; Zhongcheng Zhou; Peng Du; Meixiao Zhan; Ning Li; Xinxin Xiong; Shengjun Tang; Miao Man; Daniel T Baptista-Hon; Ligong Lu
Journal:  Signal Transduct Target Ther       Date:  2022-07-19

2.  The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera.

Authors:  Gen Li; Zhongcheng Zhou; Peng Du; Meixing Yu; Ning Li; Xinxin Xiong; Hong Huang; Zhihai Liu; Qinjin Dai; Jie Zhu; Chengbin Guo; Shanyun Wu; Daniel T Baptista-Hon; Man Miao; Lam Wai Ming; Yong Wu; Fanxin Zeng; Charlotte L Zhang; Edward D Zhang; Haifeng Song; Jianghai Liu; Johnson Yiu-Nam Lau; Andy P Xiang; Kang Zhang
Journal:  Precis Clin Med       Date:  2021-07-30

3.  COVID-19 Delta variants-Current status and implications as of August 2021.

Authors:  Flora Yu; Lok-Ting Lau; Manson Fok; Johnson Yiu-Nam Lau; Kang Zhang
Journal:  Precis Clin Med       Date:  2021-09-20

4.  Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant.

Authors:  Zhongcheng Zhou; Peng Du; Ning Li; Xinxin Xiong; Shengjun Tang; Qinjin Dai; Taorui Wang; Meixing Yu; Miao Man; Kelvin Lam; Daniel T Baptista-Hon; Wa Hou Tai; Olivia Monteiro; Weng Sam Ng; Un Man Lee; Zhihai Liu; Kang Zhang; Gen Li
Journal:  MedComm (2020)       Date:  2022-05-11

5.  Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.

Authors:  Taotao Mi; Tiantian Wang; Huifang Xu; Peng Sun; Xuchen Hou; Xinwei Zhang; Qian Ke; Jiawen Liu; Shengwei Hu; Jun Wu; Bo Liu
Journal:  Virology       Date:  2022-03-06       Impact factor: 3.616
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.